Pediatric Pharmacoepidemiology

((B-232)) (B-232) Antipsychotic use in youth and children: a cohort study from Catalonia (Spain) of treatment patterns

((B-233)) (B-233) Trends in Utilization of Chronic Asthma Medications among Publicly Insured Children in the US: 2003 to 2020

((B-234)) (B-234) Impact of Three Antimalarial Therapies on Renal Function in Nigerian Children with Uncomplicated Plasmodium Falciparum Infection

((B-235)) (B-235) Acid-Suppressive Medications and Risk of Childhood Asthma: A Meta-Analysis of Observational Epidemiological Studies

((B-236)) (B-236) Correlation of Staphylococcus aureus (S. aureus) and Methicillin-resistant Staphylococcus aureus (MRSA) carriage in caregiver and children.

((B-237)) (B-237) Risk factors for Staphylococcus aureus (S. aureus) and Methicillin-resistant Staphylococcus aureus (MRSA) carriage in children: a case-control study

((B-238)) (B-238) Risk Prediction Models for Adverse Drug Reactions in Pediatric Patients: A Systematic Review

((B-239)) (B-239) Incidence of post-partum hemorrhage and amount of blood loss in the Netherlands

((B-240)) (B-240) Treatment-Resistant Depression (TRD) in Children and Adolescents and its Life-Course Determinants

((B-241)) (B-241) Prevalence of Adolescent Drug Overdose by Drug Involvement and Intent in U.S. Medicaid, 2016-2020

((B-242)) (B-242) Identification of Infant Congenital Malformations in a Large US Insurance Claims Database

((B-243)) (B-243) Adverse Drug Events (ADEs) Associated with Outpatient Antibiotic Fills to Children by Dentists, 2014-2019